Literature DB >> 10213651

Hospitalization in peritoneal dialysis patients.

L Fried1, S Abidi, J Bernardini, J R Johnston, B Piraino.   

Abstract

Hospitalization rates are declining more rapidly for peritoneal dialysis (PD) than for hemodialysis patients. This has been postulated to be caused in part by lower peritonitis rates. However, the causes of admission have not been reexamined in the setting of declining rates. We prospectively examined our hospitalization rates, causes of admission, and impact of peritonitis on hospitalization in adult PD patients at a single center over a 4-year period. There were 274 admissions in 168 patient-years for a rate of 1.6 admissions and 13.0 hospital days per patient-year. Rates were greater for men (1.8 v 1.5; P = 0.013), patients with diabetes (2.2 v 1.4, P < 0.001), and those with a higher peritoneal equilibration test result. Creatinine clearance and sex were independent predictors in a multivariate analysis. The most common causes for admission were cardiac disease (14.6%) and peritonitis (13.5%). Peritonitis accounted for 0.21 admissions and 2.0 hospital days per patient-year. Thirty percent of the incident patients were admitted during the first 90 days of dialysis. Admissions for dehydration and glucose abnormalities were more common in the first 90 days. Overall admission rates, as well as admission rates for peritonitis, did not change over time, although hospital days per year decreased. Those admitted for peritonitis had higher peritonitis rates, more time on PD, and were more likely to be black. Eighty-one percent of the admissions for peritonitis were caused by Staphylococcus aureus, Streptococcus spp, or gram-negative/fungal peritonitis. Patients with peritonitis caused by Staphylococcus epidermidis were less likely to be admitted than patients with peritonitis caused by other organisms. To conclude, peritonitis remains a common cause of hospitalization, despite low peritonitis rates. To decrease admissions for peritonitis, attention should be focused on preventing peritonitis caused by organisms other than S epidermidis.

Entities:  

Mesh:

Year:  1999        PMID: 10213651     DOI: 10.1016/s0272-6386(99)70428-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  13 in total

1.  Comparative in vitro antimicrobial activity of vancomycin, teicoplanin, daptomycin and ceftobiprole in four different peritoneal dialysis fluids.

Authors:  S Tobudic; W Poeppl; C Kratzer; A Vychytil; H Burgmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-19       Impact factor: 3.267

2.  Microbiology of peritonitis in peritoneal dialysis patients with multiple episodes.

Authors:  Sharon J Nessim; Rosane Nisenbaum; Joanne M Bargman; Sarbjit V Jassal
Journal:  Perit Dial Int       Date:  2012-01-03       Impact factor: 1.756

3.  Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns Study.

Authors:  Neil Boudville; David W Johnson; Junhui Zhao; Brian A Bieber; Ronald L Pisoni; Beth Piraino; Judith Bernardini; Sharon J Nessim; Yasuhiko Ito; Graham Woodrow; Fiona Brown; John Collins; Talerngsak Kanjanabuch; Cheuk-Chun Szeto; Jeffrey Perl
Journal:  Nephrol Dial Transplant       Date:  2019-12-01       Impact factor: 5.992

4.  Impact of age on peritonitis risk in peritoneal dialysis patients: an era effect.

Authors:  Sharon J Nessim; Joanne M Bargman; Peter C Austin; Ken Story; Sarbjit V Jassal
Journal:  Clin J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 8.237

5.  Peritoneal fluid titer test for peritoneal dialysis-related peritonitis.

Authors:  Christine Strijack; Godfrey K M Harding; Robert E Ariano; Sheryl A Zelenitsky
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

6.  The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.

Authors:  Lei Zhang; Sunil V Badve; Elaine M Pascoe; Elaine Beller; Alan Cass; Carolyn Clark; Janak de Zoysa; Nicole M Isbel; Steven McTaggart; Alicia T Morrish; E Geoffrey Playford; Anish Scaria; Paul Snelling; Liza A Vergara; Carmel M Hawley; David W Johnson
Journal:  Perit Dial Int       Date:  2015-07-29       Impact factor: 1.756

7.  Peritoneal Dialysis as a First versus Second Option after Previous Haemodialysis: A Very Long-Term Assessment.

Authors:  Roberto José Barone; María Inés Cámpora; Nélida Susana Gimenez; Liliana Ramirez; Sergio Alberto Panese; Mónica Santopietro
Journal:  Int J Nephrol       Date:  2014-11-20

8.  Subcutaneous gentamicin injection around the cuff in treatment of resistant exit site infection in peritoneal dialysis patients: a pilot study.

Authors:  Oguzhan Sıtkı Dizdar; Ozerhan Ozer; Selahattin Erdem; Ali Ihsan Gunal
Journal:  Ther Clin Risk Manag       Date:  2017-07-20       Impact factor: 2.423

Review 9.  Reimbursement and economic factors influencing dialysis modality choice around the world.

Authors:  Paul M Just; Frank Th de Charro; Elizabeth A Tschosik; Les L Noe; Samir K Bhattacharyya; Miguel C Riella
Journal:  Nephrol Dial Transplant       Date:  2008-01-30       Impact factor: 5.992

10.  Reasons for admission and predictors of national 30-day readmission rates in patients with end-stage renal disease on peritoneal dialysis.

Authors:  Lili Chan; Priti Poojary; Aparna Saha; Kinsuk Chauhan; Rocco Ferrandino; Bart Ferket; Steven Coca; Girish Nadkarni; Jaime Uribarri
Journal:  Clin Kidney J       Date:  2017-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.